https://www.selleckchem.com/pr....oducts/blasticidin-s
ssociated with higher risk. These results may inform health care system-specific identification of patients at higher risk for POUS and drive development of preventative measures. Congenital symmastia is a relatively uncommon condition and poorly described in the literature. Although numerous studies have evaluated iatrogenic symmastia including its prevention and treatment, considerably less has been studied with regard to congenital symmastia. In this review, the authors seek to consolidate the literature published thus far
Like
Comment
Share
